Showing results (751-760 of 1,183) with videos related to

Sort By:
Pageof 119
Growth Factors (Chur, Switzerland)|November 14, 2014
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibitionBenjamin D Ferguson, Maria S Tretiakova, Mark W Lingen, et al.
Growth Factors (Chur, Switzerland)|November 21, 2014
Investigation of the interactions between the EphB2 receptor and SNEW peptide variantsBuyong Ma, Stephanie Kolb, Michael Diprima, et al.
Growth Factors (Chur, Switzerland)|October 6, 2000
Extracellular FGF-1 inhibits cytoskeletal organization and promotes fibroblast motilityQ Ding, C L Gladson, C R Guidry, et al.
Growth Factors (Chur, Switzerland)|October 6, 2000
Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel diseaseG S Howarth, C J Xian, L C Read
Growth Factors (Chur, Switzerland)|September 25, 1999
Distinct functional domains of TGF-beta bind receptors on endothelial cellsS W Qian, N Dumont, M D O'Connor-McCourt, et al.
Growth Factors (Chur, Switzerland)|March 8, 2000
Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudimentsA Haaijman, E H Burger, S W Goei, et al.
Growth Factors (Chur, Switzerland)|March 8, 2000
Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclinsL Kanter-Lewensohn, A Dricu, L Girnita, et al.
Growth Factors (Chur, Switzerland)|May 9, 2000
Role of the Bsk/Iyk non-receptor tyrosine kinase for the control of growth and hormone production in RINm5F cellsC Annerén, M Welsh
Growth Factors (Chur, Switzerland)|May 9, 2000
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activatorsA Copeta, D Tavian, E Marchina, et al.
Growth Factors (Chur, Switzerland)|May 9, 2000
A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancerI D Davis, D W Maher, J S Cebon, et al.
Pageof 119